Jazz CEO Bruce Cozadd to retire by end of 2025; company to search for successor

Jazz Pharmaceuticals plc

Bruce Cozadd notified Board of intent to retire as CEO upon appointment of successor.
Formal search process will consider both internal and external candidates for CEO.
After retiring as CEO, Cozadd will continue to serve as Chairperson of the Board.
Cozadd remains CEO until successor is appointed; transition expected by end of 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.